Duration of previous treatment as a prognostic factor in metastatic colorectal cancer treated with trifluridine/tipiracil

Elina Skuja; Aija Gerina-Berzina; Alinta Hegmane; Zanete Zvirbule; Eva Vecvagare; Gunta Purkalne

doi:10.3892/mco.2018.1600

Duration of previous treatment as a prognostic factor in metastatic colorectal cancer treated with trifluridine/tipiracil

Elina Skuja
, Aija Gerina-Berzina
, Alinta Hegmane
, Zanete Zvirbule
, Eva Vecvagare
, Gunta Purkalne

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	699-702
Number of pages	4
Journal	Molecular and Clinical Oncology
Volume	8
Issue number	5
DOIs	https://doi.org/10.3892/mco.2018.1600
Publication status	Published - May 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords*

trifluridine/tipiracil
TAS-102
colorectal cancer
refractory

Field of Science

3.2 Clinical medicine

Publication Type*

1.1. Scientific article indexed in Web of Science and/or Scopus database

Access to Document

10.3892/mco.2018.1600

Cite this

@article{10d5d299ed5f4e828efd2b0ddd4d0620,

title = "Duration of previous treatment as a prognostic factor in metastatic colorectal cancer treated with trifluridine/tipiracil",

keywords = "trifluridine/tipiracil, TAS-102, colorectal cancer, refractory",

author = "Elina Skuja and Aija Gerina-Berzina and Alinta Hegmane and Zanete Zvirbule and Eva Vecvagare and Gunta Purkalne",

year = "2018",

month = may,

doi = "10.3892/mco.2018.1600",

language = "English",

volume = "8",

pages = "699--702",

journal = "Molecular and Clinical Oncology",

issn = "2049-9450",

publisher = "Spandidos Publications UK",

number = "5",

}

TY - JOUR

T1 - Duration of previous treatment as a prognostic factor in metastatic colorectal cancer treated with trifluridine/tipiracil

AU - Skuja, Elina

AU - Gerina-Berzina, Aija

AU - Hegmane, Alinta

AU - Zvirbule, Zanete

AU - Vecvagare, Eva

AU - Purkalne, Gunta

PY - 2018/5

Y1 - 2018/5

KW - trifluridine/tipiracil

KW - TAS-102

KW - colorectal cancer

KW - refractory

UR - https://www.spandidos-publications.com/10.3892/mco.2018.1600

U2 - 10.3892/mco.2018.1600

DO - 10.3892/mco.2018.1600

M3 - Article

SN - 2049-9450

VL - 8

SP - 699

EP - 702

JO - Molecular and Clinical Oncology

JF - Molecular and Clinical Oncology

IS - 5

ER -

Duration of previous treatment as a prognostic factor in metastatic colorectal cancer treated with trifluridine/tipiracil

UN SDGs

Keywords*

Field of Science

Publication Type*

Access to Document

Other files and links

Cite this